Susquehanna International Group’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7039 |
|
|
2022
Q1 | – | Sell |
-273,100
| Closed | -$713K | – | 6881 |
|
|
2021
Q4 | $713K | Buy |
273,100
+92,741
| +51% | +$242K | ﹤0.01% | 3314 |
|
|
2021
Q3 | $561K | Buy |
180,359
+123,075
| +215% | +$383K | ﹤0.01% | 3534 |
|
|
2021
Q2 | $213K | Buy |
57,284
+499
| +0.9% | +$1.86K | ﹤0.01% | 4784 |
|
|
2021
Q1 | $196K | Buy |
56,785
+28,496
| +101% | +$98.4K | ﹤0.01% | 4801 |
|
|
2020
Q4 | $95K | Sell |
28,289
-1,364
| -5% | -$4.58K | ﹤0.01% | 4506 |
|
|
2020
Q3 | $104K | Buy |
29,653
+18,424
| +164% | +$64.6K | ﹤0.01% | 4085 |
|
|
2020
Q2 | $52K | Buy |
+11,229
| New | +$52K | ﹤0.01% | 4025 |
|
|
2019
Q2 | – | Sell |
-42,845
| Closed | -$407K | – | 5195 |
|
|
2019
Q1 | $407K | Buy |
+42,845
| New | +$407K | ﹤0.01% | 2016 |
|